VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 109 filers reported holding VIKING THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.57 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $5,440 | -5.9% | 2,000 | 0.0% | 0.00% | – |
| Q2 2022 | $5,780 | -3.7% | 2,000 | 0.0% | 0.00% | – |
| Q1 2022 | $6,000 | -34.8% | 2,000 | 0.0% | 0.00% | – |
| Q4 2021 | $9,200 | -26.8% | 2,000 | 0.0% | 0.00% | – |
| Q3 2021 | $12,560 | +4.8% | 2,000 | 0.0% | 0.00% | – |
| Q2 2021 | $11,980 | -5.3% | 2,000 | 0.0% | 0.00% | -100.0% |
| Q1 2021 | $12,650 | +12.3% | 2,000 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $11,260 | -15.0% | 2,000 | -12.1% | 0.00% | 0.0% |
| Q3 2020 | $13,241 | -19.9% | 2,275 | -0.8% | 0.00% | 0.0% |
| Q2 2020 | $16,540 | +292.7% | 2,294 | +154.9% | 0.00% | – |
| Q1 2020 | $4,212 | -41.6% | 900 | 0.0% | 0.00% | -100.0% |
| Q4 2019 | $7,218 | +16.6% | 900 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $6,192 | -17.1% | 900 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $7,470 | -16.5% | 900 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $8,946 | – | 900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DAFNA Capital Management LLC | 450,900 | $2,624,000 | 0.85% |
| Sio Capital Management, LLC | 709,780 | $4,131,000 | 0.82% |
| KNOTT DAVID M | 218,102 | $1,269,000 | 0.74% |
| ArrowMark Colorado Holdings LLC | 7,988,635 | $46,494,000 | 0.44% |
| Park West Asset Management LLC | 1,457,507 | $8,483,000 | 0.33% |
| VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. | 1,657 | $10,000 | 0.18% |
| Virtus ETF Advisers LLC | 42,507 | $247,000 | 0.13% |
| Cornerstone Capital, Inc. | 125,465 | $730,000 | 0.10% |
| L & S Advisors Inc | 114,988 | $669,000 | 0.09% |
| EXANE DERIVATIVES | 44,877 | $261,170,000 | 0.08% |